Drugmakers agree to participate in second round of price negotiations All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals ... Britain's blue-chip FTSE 100 ended flat on ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in 2025.

Kathy Hochul to reverse course on a recently passed state law that shields the identities of healthcare providers who prescribe and mail the abortion pill mifepristone. In a letter to Hochul on ...

Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 monoclonal antibody targeting TL1A, for the ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge. Explore Teva Pharmaceutical Indus stock price, quotes, charts and forecasts with Benzinga. Stay updated on ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

Blue Origin launched its 10th space tourism mission this morning (Feb. 25), sending six paying passengers to suborbital space. After a slight delay due to a hold, Blue Origin's suborbital New ...

Acelyrin (NASDAQ:SLRN) stock in focus as the company adopts a poison pill to counter rapid stock acquisition by Tang Capital Partners. Read more here.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

By Lisa Lerer The country’s largest manufacturer of abortion pills is wading into the first major legal battle over abortion of President Trump’s second term. The company, GenBioPro ...